A Study of the Effect of Patient Education (Talking Health Together) in Improving Doctor-patient Communication

August 19, 2011 updated by: AstraZeneca

A Multi-centre, Randomised Trial in Ontario to Evaluate the Efficacy of Talking Health Together T.M. (T.H.T. in Practice), a Communication Education Intervention for Primary Care Patients With Chronic Disease.

This study is being carried out to see if patients make the lifestyle changes or take their medication as instructed by their doctor during their visit as a result of the T.H.T. patient-education training. Proper information exchange between doctors and patients is an important part of quality health care. Although many patients would like more information, they often do not ask for it directly during doctor-patient visits. The patient-training in this study specifically aims at improving patient participation during medical appointments by building communication skills such as requests for information and sharing health concerns with the doctor.

Study Overview

Study Type

Interventional

Enrollment (Actual)

322

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ontario
      • Burlington, Ontario, Canada
        • Research Site
      • Hamilton, Ontario, Canada
        • Research Site
      • Kitchener-Waterloo, Ontario, Canada
        • Research Site
      • Mississauga, Ontario, Canada
        • Research Site
      • Oakville, Ontario, Canada
        • Research Site

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Male or female, aged 40 years of age or greater
  • Clinical documentation of diagnosis not to target of at least one of the following: Type II Diabetes Mellitus, Hypertension or Hypercholesterolemia
  • Receive a prescribed medication for the chronic disease for which they were included in the study

Exclusion Criteria:

  • Patients in active phase of cancer treatment (i.e. chemotherapy or radiotherapy at time of study).
  • Inability to carry out the encounter with their physician in English without need of assistance
  • Uncomfortable using a computer for routine activities such as regular access to the web and e-mail.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: THT PACE eLearning module
The PACE (prepare, ask, check, express) training methodology will be available to patients before their 2nd doctor visit
Patient training
Active Comparator: THT PACE eLearning module & nurse-led workshop training
THT PACE eLearning and then nurse-led workshop for training on PACE methodology
Patient training
Placebo Comparator: Usual care
Patients just go to their doctor as they normally would but get some disease specific information in the form of brochures as do intervention arms

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
To evaluate the impact, compared to Usual Care, of training interventions on patients with chronic disease on patient participation in primary care encounters assessed after intervention.
Time Frame: once
once

Secondary Outcome Measures

Outcome Measure
Time Frame
physician satisfaction and sense of partnership with the doctor-patient encounter;
patient perception of quality of doctor-patient communication and relationship and patient confidence in own ability to communicate effectively with their doctor;
Time Frame: Twice
Twice
patient perception of the management of their chronic disease(s); and patient recall of discussions of lifestyle recommendations and chronic disease medications discussed during the encounter.
Time Frame: Twice
Twice

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Dr. Marie-Thérèse Lussier, MD, BSc., MSc., FCMFC, Université de Montréal

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2009

Primary Completion (Actual)

August 1, 2010

Study Completion (Actual)

August 1, 2010

Study Registration Dates

First Submitted

April 8, 2009

First Submitted That Met QC Criteria

April 9, 2009

First Posted (Estimate)

April 10, 2009

Study Record Updates

Last Update Posted (Estimate)

August 22, 2011

Last Update Submitted That Met QC Criteria

August 19, 2011

Last Verified

October 1, 2010

More Information

Terms related to this study

Other Study ID Numbers

  • THT in practice

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Doctor-patient Communication Improvement

Clinical Trials on placebo

3
Subscribe